STOCK TITAN
  1. Home
  2. Sec-filings
  3. CUE
  4. [EFFECT] Cue Biopharma, Inc. SEC Filing

[EFFECT] Cue Biopharma, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 31, 2026 4:00 P.M.
Form: S-3
CIK: 0001645460
Company Name: Cue Biopharma, Inc.
File Number: 333-294366

Source: View Original Filing on SEC EDGAR

Cue Biopharma Inc

NASDAQ:CUE

View CUE Stock Overview →

CUE Rankings

#6079 Ranked by Market Cap
N/A Ranked by Dividends

CUE Latest News

Mar 27, 2026
Cue Biopharma Announces CEO Transition
Mar 26, 2026
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026
Mar 16, 2026
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Mar 9, 2026
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026
Feb 17, 2026
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases

CUE Latest SEC Filings

Mar 27, 2026
[8-K] Cue Biopharma, Inc. Reports Material Event
Mar 17, 2026
[S-3] Cue Biopharma, Inc. Shelf Registration Statement
Mar 16, 2026
[ARS] Cue Biopharma, Inc. SEC Filing
Mar 16, 2026
[DEF 14A] Cue Biopharma, Inc. Definitive Proxy Statement
Mar 16, 2026
[10-K] Cue Biopharma, Inc. Files Annual Report

CUE Stock Data

22.45M
78.15M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON